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Summary
Upon cell adhesion to extracellular matrix proteins, focal adhesion kinase (FAK) rapidly undergoes
autophosphorylation on its Tyr-397 which consequently serves as a binding site for the Src homology 2
domains of the Src family protein kinases and several other intracellular signaling molecules. In this study,
we have attempted to examine the eﬀect of the FAK Y397F mutant on v-Src-stimulated cell transformation
by establishing an inducible expression of the Y397F mutant in v-Src-transformed FAK-null (FAK)/))
mouse embryo ﬁbroblasts. We found that the FAK Y397F mutant had both positive and negative eﬀects
on v-Src-stimulated cell transformation; it promoted v-Src-stimulated invasion, but on the other hand it
inhibited the v-Src-stimulated anchorage-independent cell growth in vitro and tumor formation in vivo . The
positive eﬀect of the Y397F mutant on v-Src-stimulated invasion was correlated with an increased
expression of matrix metalloproteinase-2, both of which were inhibited by the speciﬁc phosphatidylinositol
3-kinase inhibitor wortmannin or a dominant negative mutant of AKT, suggesting a critical role for the
phosphatidylinositol 3-kinase/AKT pathway in both events. However, the expression of the Y397F mutant
rendered v-Src-transformed FAK)/) cells susceptible to anoikis, correlated with suppression on v-Src-
stimulated activation of ERK and AKT. In addition, under anoikis stress, the induction of the Y397F
mutant in v-Src-transformed FAK)/) cells selectively led to a decrease in the level of p130Cas, but not other
focal adhesion proteins such as talin, vinculin, and paxillin. These results suggest that FAK may increase
the susceptibility of v-Src-transformed cells to anoikis by modulating the level of p130Cas.
Abbreviations: Cas – Crk-associated substrate; ERK – extracellular signal-regulated kinase; FAK – focal
adhesion kianse; HA – hemagglutinin; IB – immunoblotting; IP – immunoprecipitation; JNK – c-Jun
N-terminal kinase; MMP – matrix metalloproteinase; PI3K – phosphatidylinositol 3-kinase; SH – Src
homology; Src – sarcoma; STAT3 – signal transducers and activators of transcription 3; Tet – tetracycline;
Tyr – tyrosine; v-Scr – viral Scr; Wt – wild type
Introduction
The v-src oncogene, which was ﬁrst identiﬁed from
the transforming gene of Rous sarcoma virus,
encodes a constitutively activated form of c-Src
nonreceptor tyrosine kinase [1–3]. Cell transfor-
mation by v-Src results in a wide variety of
phenotypic changes, including morphological
transformation, increase in cell migration or inva-
siveness, and acquisition of anchorage and
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growth-factor independence, and tumorigenicity
[4]. Activation of several intracellular signal trans-
duction pathways has shown to be associated with
transforming potential of activated Src, such as the
Ras/ERK [5], the PI3K/AKT [6], and the STAT3/
Myc [7] pathways. Considerable evidence now
implicates that elevated expression and/or activity
of Src is associated with human cancers [8].
FAK, a 125-kDa cytoplasmic protein tyrosine
kinase localized in focal contacts, was originally
identiﬁed as a highly tyrosine-phosphorylated
protein in v-Src-transformed chicken ﬁbroblasts
[9]. The full-length cDNA of mouse FAK was
independently cloned on the basis of homology
cloning [10]. FAK is now known to play a crucial
role in the control of integrin-mediated cellular
functions including cell spreading [11], cell migra-
tion [12, 13], cell cycle progression [14, 15], and cell
survival [16–19]. In addition to cell adhesion, the
tyrosine phosphorylation of FAK is also stimu-
lated by growth factors [20–22] as a result of Src
activation by growth factor receptor [22] and/or
FAK association with growth factor receptor [23].
Increased level of FAK has been found in a variety
of invasive human tumors and has been implicated
to play a role in tumor progression to an invasive
phenotype [24–27].
The tyrosine residue 397 has been identiﬁed as
the major site of FAK autophosphorylation [28]
and the binding site for the Src homology (SH) 2
domains of the Src family kinases [28, 29], PI3K
[30, 31], phospholipase C-c1 [32], and Grb7 [33].
After binding to FAK, the Src family kinases (Src
or Fyn) phosphorylates FAK on particular tyro-
sine residues, leading to activation of the FAK
catalytic activity [34] and creating a binding site
for the Grb2/Sos complex that relays signals to the
Ras/ERK pathway [35, 36]. In addition, Src can
also phosphorylate FAK-associated proteins, such
as paxillin [37] and p130Cas [38] to transmit signals.
Through these mechanisms, Src intimately coop-
erates with FAK to regulate various aspects of cell
functions.
Crk-associated substrate (Cas or p130Cas) was
originally identiﬁed and cloned as a highly tyrosine
phosphorylated protein in cells transformed by
v-Src [39] or v-Crk [40]. It contains an NH2-terminal
SH3 domain, a substrate domain that consists
of 15 YXXP motifs, and a COOH-terminal
Src-binding domain [41, 42]. The SH3 domain of
p130Cas could bind proline-rich sequences of
various signaling molecules such as FAK [43],
guanine nucleotide exchange factor C3G [44],
tyrosine phosphatase PTP-PEST [45]. p130Cas-
deﬁcient mouse embryonic ﬁbroblasts showed
impaired actin bundling and cell migration and
were refractory to be transformed by activated Src
[46]. The phosphorylated p130Cas has been dem-
onstrated to be essential for FAK to promote cell
migration [47], cell cycle progression [15] and cell
survival [18].
Since the Tyr-397 of FAK is the binding site for
Src and other signaling molecules, mutation at this
site was found to impair the function of FAK [13,
48] and could serve as a dominant negative version
of FAK capable of inhibiting cell cycle progress
[14] and cell migration [49]. In this study, we set
out to examine the eﬀect of the FAK Y397F
mutant on the v-Src-stimulated cell transforma-
tion. Our results revealed that the expression of the
Y397F mutant in v-Src-transformed FAK)/) cells
promotes their invasiveness, but inhibits their




The 24-well transwell chamber for invasion assay
was purchased from Costar. Methylcellulose
(Methocel 65HG) was purchased from Fluka.
Hygromycin B, SP600125, and PD98059 were
purchased from Calbiochem. The monoclonal
anti-talin, anti-vinculin, and wortmannin were
purchased from Sigma-Aldrich. The monoclonal
anti-FAK (clone 77), anti-phosphotyrosine
(PY20), and anti-STAT3 were purchased from
BD Transduction Laboratories. The rabbit poly-
clonal anti-p130Cas (C-20), anti-Src (N-16), anti-ERK
(K-23), anti-JNK (C-17), anti-MMP2 (C-19) were
purchased from Santa Cruz Biotechnology. The
rabbit polyclonal anti-phosphoERK (Thr202/
Tyr204), anti-phosphoJNK (Thr183/Tyr185),
anti-phosphoSTAT3 (Tyr705), anti-AKT, and
anti-phosphoAKT (Ser473) were purchased from
Cell Signaling Technology. The rabbit polyclonal
anti-phosphoSrc (Tyr418) and anti-phosphoFAK
(respectively for Tyr397, Tyr407, Tyr576, Tyr861,
and Tyr925) were purchased from Biosource. The
monoclonal anti-hemagglutinin (HA) epitope was
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purchased from Roche. The mouse ascites con-
taining monoclonal anti-Src (peptide 2–17) pro-
duced by the hybridoma (ATCC, CRL-2651) was
collected in our laboratory.
Cell lines
Tet-FAK-Y397F cells harboring a tetracycline
repression system for inducible FAK Y397F
expression were generated from FAK)/) ﬁbro-
blasts and kindly provided by Dr. Steven Hanks at
Vanderbilt University, as described [49]. To gen-
erate v-Src-transformed Tet-FAK-Y397F cells
(designated as Tet-FAK-Y397F/v-Src), Tet-FAK-
Y397F cells were grown on 60-mm dishes and
co-transfected with 4 lg of pM-vSrc and 0.2 lg of
pREP3 using lipofectamine following the manu-
facturer’s instructions. To generate hygromycin-
resistant control cells, Tet-FAK-Y397F cells were
transfected with 0.2 lg of pREP3 alone. The cells
were selected in medium containing 100 U/ml
hygromycin and 2 lg/ml tetracycline. 10 days
later, the drug-resistant colonies were pooled,
expanded, and subjected to analysis for their
morphology, the expression level of Src, and
inducible expression of the FAK Y397F mutant.
The expression of FAK Y397F was induced
by incubating the cells in the medium without
tetracycline.
Soft agar-colony formation assay
5 · 103 cells were suspended in 2 ml of Dulbecco’s
modiﬁed Eagle’s medium containing 0.3% agar
and 10% serum ± 2 lg/ml tetracycline and added
onto a layer of medium containing 0.5% agar and
10% serum in a 60-mm dish. 2 ml of medium
containing 0.3% agar and 10% serum ±2 lg/ml
tetracycline was added to the dish every other day.
Each experiment was performed in duplicate.
After 21 days, the number of colonies
(>1.5 mm) was measured.
Matrigel invasion assay
104 cells in 250 ll of serum-free medium were
added to an inner cup of the 24-well transwell
chamber that had been coated with 150 ll of
Matrigel (1:10 dilution in serum-free medium).
Seven-hundred and ﬁfty microlitre of medium
supplemented with 10% serum was added to the
outer cup. After 12 h, cells that had migrated
through Matrigel and ﬁlter membrane with 8-lm
pores were ﬁxed, stained, and counted under a
light microscope. Each experiment was performed
in triplicate.
Gelatin zymography
5 · 106 cells were plated on 10-cm dishes in growth
medium with or without tetracycline for 24 h and
then incubated in 5 ml of serum-free medium with
or without tetracycline for another 12 h. The
conditioned media was collected, concentrated by
centrifugation with Ultra-4 centrifugal ﬁlter
(Millipore-Amicon), and separated in a 7.5%
SDS-polyacrylamide gel electrophoresis containing
0.1% gelatin. The gel was washed several times in
Tris buﬀer (50 mM Tris, pH 7.4) containing 2.5%
(v/v) Triton X-100 at room temperature, followed
by further incubation in substrate buﬀer (50 mM
Tris, pH 7.4, 10 mM CaCl2, 150 mM NaCl) at
37 C for 24 h. The gel was ﬁxed in 10% methanol
and 10% acetic acid for 10 min and gelatinolytic
activity was visualized following Coomassie blue
staining.
Anoikis assay
5 · 106 cells were suspended in 5 ml of 2X
Dulbecco’s modiﬁed Eagle’s medium containing
20% serum and then mixed with 5 ml of 1%
methylcellulose. The mixture was plated onto a
10-cm culture dish for 10 h. The cells were harvested
by centrifugation and the cell survival rate was
determined by trypan blue exclusion, as described
previously [50]. Each experiment was performed in
duplicate.
Tumorigenicity in nude mice
Five to six-week-old female nude mice were
subcutaneously injected with 5 · 105 Tet-FAK-
Y397F/Hygro cells on the left ﬂank and 5 · 105
Tet-FAK-Y397F/v-Src cells on the right ﬂank. To
control the expression of the FAK Y397F mutant
in vivo , nude mice were fed with water containing
with or without tetracycline (150 lg/ml). At 14 or
30 days after injection, the size (length · width ·
height) of tumor was measured by a caliper. Mice
were euthanasized and tumors were surgically
removed. The tumors were homogenized and
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analyzed for the expression of the FAK Y397F
mutant.
Immuoprecipitation and immunoblotting
Cells were solubilized in 1% NP-40 lysis buﬀer
[22] containing protease inhibitors (1 mM phenyl-
methylsulfonyl ﬂuoride, 0.2 trypsin inhibitory
units/ml aprotinin, and 20 lg/ml leupeptin). The
lysates were centrifuged for 10 min at 4 C to
remove debris, and the protein concentrations
were determined using the Bio-Rad Protein Assay.
Immunoprecipitation and immunoblotting were
performed as described previously [51].
Immunoﬂuorescent staining
Cells were grown on glass coverslips for 48 h
prior to ﬁxation in phosphate-buﬀered saline
containing 4% paraformadehyde at room temper-
ature for 30 min. Samples were permeabilized with
phosphate-buﬀered saline containing 0.3% Triton
X-100 for 30 min. Coverslips were stained with
primary antibody for 60 min and followed by goat
anti-rabbit Cy5-conjugated or anti-mouse tetram-
ethyl rhodamine isothiocyanate-conjugated sec-
ondary antibodies (Jackson ImmunoReseach
Laboratories) at 4 lg/ml for 60 min. Polyclonal
anti-FAK and monoclonal anti-paxillin were
diluted 1:200 before use. Fluorescein isothiocyanate-
conjugated phalloidin (Sigma-Aldrich) at 2 lM
was used to stain actin ﬁlaments. Coverslips were
mounted in anti-fading solution and viewed using
a Zeiss LSM laser-scanning confocal microscope.
Statistics
Statistical analyses were performed with Student’s
t-test. Diﬀerences were considered to be statisti-
cally signiﬁcant at p<0.05.
Results
v-Src phosphorylates FAK independently of
the Tyr-397
To examine the eﬀect of the FAK Y397F mutant
on v-Src-stimulated cell transformation, a tetra-
cycline repression system for inducible expression
of the Y397F mutant was established in MEF
FAK)/) cells (Tet-FAK-Y397F/Hygro cells) and those
stably expressing v-Src (Tet-FAK-Y397F/v-Src
cells). When those cells were grown in the medium
containing tetracycline, the expression of the
Y397F mutant was suppressed. In contrast, the
Y397F mutant was induced to express by tetracy-
cline withdrawal (Figure 1a). The induced level of
the Y397F mutant in FAK)/) cells was compara-
ble to that of endogenous FAK in FAK+/+cells
Figure 1. v-Src phosphorylates FAK independently of the
Tyr-397 of FAK. (a) A tetracycline repression system for
inducible expression of the FAK Y397F mutant was estab-
lished in FAK)/) cells (Tet-FAK-Y397F/Hygro) or those sta-
bly expressing v-Src (Tet-FAK-Y397F/v-Src). When those cells
were grown in the medium with tetracycline (2 lg/ml), the
expression of the Y397F mutant remained un-induced (U). In
contrast, when those cells were grown in the medium without
tetracycline, the expression of the Y397F mutant was induced
(I). 48 h after induction, the cells were lyzed and subjected to
analysis for the expression and phosphorylation of FAK and
Src. FAK was immunoprecipitated by anti-FAK and ana-
lyzed by immunoblotting with anti-phosphotyrosine or anti-
FAK. For the expression and phosphorylation of Src, an
equal amount of whole cell lysates was analyzed by immuno-
blotting with anti-phosphoSrcY418 and anti-Src. (b) FAK
was immunoprecipitated by anti-FAK and analyzed by
immunoblotting with antibodies speciﬁcally recognizing phos-
phorylated FAK at Y397, Y407, Y576, Y861, or Y925. These
residues, except Y397, were known to be phosphorylated by
c-Src.
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(data not shown). Although a similar level of the
Y397F mutant was induced in both Tet-FAK-
Y397F/v-Src cells and Tet-FAK-Y397F/Hygro
cells, the tyrosine phosphorylation level of the
Y397F mutant was much higher in Tet-FAK-
Y397F/v-Src cells than in Tet-FAK-Y397F/Hygro
cells (Figure 1a). In addition, the phosphorylation
of the Y397F mutant on particular tyrosine residues
known to be phosphorylated by c-Src was all
increased in the cells expressing v-Src (Figure 1b),
indicating that the Tyr-397 of FAK is dispensable
for v-Src to phosphorylate FAK.
Induction of the FAK Y397F expression in
v-Src-transformed FAK )/) cells induces a more
spread morphology, accompanied by a more
organized actin cytoskeleton and an increased
formation of focal adhesions
Our results showed that v-Src was able to trans-
form the morphology of the FAK)/) cells into
long spindle-like phenotype (Figure 2a). The
induction of the FAK Y397F expression caused
Tet-FAK-Y397F/v-Src cells to spread (Figure 2a),
accompanied by more organized actin ﬁlaments
(Figure 2d). By time-lapse video-microscopy, we
found that Tet-FAK-Y397F/v-Src cells did not
spread until 9 h after induction (Figure 2b), cor-
related with the expression of the Y397F mutant in
those cells (Figure 2c). The induced Y397F mutant
was localized in focal adhesions, revealed by
co-staining a focal adhesion protein, paxillin
(Figure 2d). The FAKY397F-induced cell spreading
was associated with an increased formation of focal
adhesions (Figure 2d).
Induction of the FAK Y397F expression potentiates
v-Src-stimulated invasion, but suppresses
v-Src-stimulated anchorage-independent cell growth
in vitro and tumor growth in vivo
The induction of the Y397F mutant potentiated the
ability of v-Src to stimulate invasion (Figure 3a),
correlated with increased gelatinase activity in the
conditioned medium (Figure 3b). Based on the
position of the major clearing zone on the zymo-
graph, MMP-2, which has a molecular mass about
66-kDa, was speculated. Our result (Figure 3c)
showed that the amount of MMP-2 in the condi-
tioned medium from Tet-FAK-Y397F/v-Src cells
was higher than that from Tet-FAK-Y397F/Hygro
cells. Importantly, the induction of the Y397F
mutant further increased (twofold) the amount of
secreted MMP-2 from Tet-FAK-Y397F/v-Src
cells. These results suggest that the promotion of
v-Src-stimulated invasion by the FAKY397Fmutant
may be at least through its stimulatory eﬀect on the
MMP-2 expression.
Figure 2. FAK Y397F mutant induces a more spread cell
morphology, accompanied by a more organized actin cyto-
skeleton and an increased formation of focal adhesions. (a)
The expression of the FAK Y397 mutant was induced (I) or
un-induced (U) in Tet-FAK-Y397F/Hygro cells and Tet-
FAK-Y397F/v-Src cells. Forty-eight hours after induction,
micrographs were taken under a diﬀerential interference con-
trast microscope at magniﬁcation 400·. (b) Tet-FAK-Y397F/
v-Src cells were allowed to express the Y397F mutant. The
time-lapse micrographs were taken every 5 min for 12 h to
record the morphological changes of the cells. The representa-
tive micrographs at 0, 3, 6, 9, and 12 h are shown (c). Tet-
FAK-Y397F/v-Src cells were allowed to express the Y397F
mutant for various times and lyzed. An equal amount of cell
lysates was analyzed by immunoblotting with anti-FAK. (d).
The cells were maintained in the medium with or without
tetracycline. Forty-eight hours later, the cells were ﬁxed and
co-stained for the actin ﬁlaments, FAK, and paxillin.
575
Next, we examinedwhether induction of the FAK
Y397F mutant has an eﬀect on v-Src-stimulated
anchorage-independent cell growth. To our surprise,
induction of the Y397F mutant completely inhibited
Tet-FAK-Y397F/v-Src cells to grow in soft agar
(Figure 4a). To further examine the eﬀect of the FAK
Y397F mutant on v-Src-stimulated tumor growth
in vivo, equal numbers of Tet-FAK-Y397F/v-Src cells
and Tet-FAK-Y397F/Hygro cells were subcutane-
ously injected into nude mice. The expression of the
FAK Y397F mutant in vivo was controlled by
addition with or without tetracycline in drinking
water for nude mice. Two weeks after injection, Tet-
FAK-Y397F/v-Src cells formed measurable tumors
only in the nudemice fed with tetracycline-containing
water, but not in the nude mice fed with tetracycline-
free water (Figure 4b). One month after injection, the
tumors in the mice drinking tetracycline-containing
water were threefold bigger than those in the mice
drinking tetracycline-free water (Figure 4b). To ver-
ify whether the induction of FAK Y397F mutant
was tightly controlled in vivo, the tumors were
excised from the mice and subjected to analysis for
the expression of the Y397F mutant. The result
(Figure 4c) clearly showed that addition of tetracy-
cline in drinking water tightly suppressed the expres-
sion of the Y397Fmutant in Tet-FAK-Y397F/v-Src
cells in vivo. Together, our results indicate that the
FAK Y397F mutant suppresses v-Src-stimulated
anchorage-independent cell growth in vitro and
tumor formation in vivo.
Activation of the PI3K pathway is important for the
FAK Y397F mutant to promote v-Src-stimulated
Matrigel invasion
To examine the pathway(s) selectively promoted
by the FAK Y397F mutant, the phosphorylation
(activation) status of several signaling molecules
was examined. Among the molecules examined
in this study, we found that the induction of the
Y397F mutant selectively increased the activation
of AKT, ERK, and JNK, but not STAT3, in
Tet-FAK-Y397F/v-Src cells (Figure 5a). Next,
we employed a pharmacological approach to
examine which of these molecules may be
involved in the FAK Y397F promotion of
v-Src-stimulated invasion. Our results showed that
the speciﬁc PI3K inhibitor wortmannin, but not
the speciﬁc inhibitor for MEK or JNK, eﬃciently
blocked the ability of the Y397F mutant to
Figure 3. FAK Y397F mutant potentiates v-Src-stimulated
invasion and MMP2 expression. (a) The expression of the
FAK Y397F mutant was induced (I) or un-induced (U) in
Tet-FAK-Y397F/Hygro cells and Tet-FAK-Y397F/v-Src cells.
Forty-eight hours after induction, the cells (104) were sub-
jected to a Matrigel invasion assay in the presence or absence
of tetracycline. Twelve hours later, the cells invading through
Matrigel to the lower side of the membrane were ﬁxed,
stained, and counted. The experiments were performed in
triplicate. The value (mean ± SE) was from nine data points
from three separate experiments. (b) The cells were allowed to
express the Y397F mutant for 24 h and then the medium was
replaced by serum-free medium with or without tetracycline.
Twelve hours later, the conditioned medium was collected,
concentrated, and analyzed by gelatin zymography. The clear
zones represent the activity of gelatinases. (c) An equal vol-
ume of the conditioned medium, as described in the panel B,
was analyzed by immunoblotting with anti-MMP2. The level
of MMP2 was measured and expressed as – fold relative to
that of Tet-FAK-Y397F/Hygro cells without induction of the
Y397F mutant. The value (mean ± SE) was from three
experiments.
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promote v-Src-stimulated invasion (Figure 5b)
and MMP-2 expression (Figure 5c). To examine
the role of AKT in this process, a dominant-
negative version of AKT was expressed in
Tet-FAK-Y397F/v-Src cells, leading to decreased
invasion promoted by the Y397F mutant (Fig-
ure 5d). These results together suggest that the
activation of the PI3K/AKT pathway by the
FAK Y397F mutant is critical for v-Src-induced
invasiveness.
Figure 4. FAK Y397F mutant suppresses v-Src-stimulated anchorage-independent cell growth in vitro and tumor formation in
nude mice. (a) The expression of the FAK Y397F mutant was induced (I) or un-induced (U) in Tet-FAK-Y397F/Hygro cells and
Tet-FAK-Y397F/v-Src cells. Forty-eight hours after induction, the cells were subjected to a soft agar-colony formation assay in the
presence or absence of tetracycline. Twenty-one days later, cell colonies were enumerated. The experiments were performed in
duplicate. The value (mean ± SE) was from six data points from three experiments. (b) Forty-eight hours after induction, the cells
were subcutaneously injected to nude mice. Each mouse received two injections with Tet-FAK-Y397F/Hygro cells on the left and
Tet-FAK-Y397F/v-Src cells on the right. To control the expression of the FAK Y397F mutant in vivo , nude mice were fed with
water containing with or without tetracycline (150 lg/ml). At 14 or 30 days after injection, the size (length · width · height) of tu-
mor was measured by a caliper. The value (mean ± SE) of each experimental group was from 15 mice from three separate experi-
ments. Arrowhead indicates the location where Tet-FAK-Y397F/Hygro cells were injected. Dashed line circles the tumors formed
by Tet-FAK-Y397F/v-Src cells. (c) Thirty days after injection, the tumors formed by Tet-FAK-Y397F/v-Src cells were excised
from the nude mice, homogenized, and analyzed by immunoblotting with monoclonal anti-FAK or anti-actin. The representative
result shown includes four tumor samples; two of which were excised from mice fed with tetracycline-containing water, and the
other two were from mice fed with tetracycline-free water. Note that no detectable expression of the FAK Y397F mutant in the
tumors from the mice fed with tetracycline-containing water.
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Induction of the FAK Y397F expression increases
the susceptibility of v-Src-expressed cells to anoikis
To examine whether the inhibitory eﬀect of the
FAK Y397F mutant on v-Src-stimulated tumor
growth was because of its inhibitory eﬀect on
cell proliferation, the growth rate of the cells
with or without FAK Y397F induction was
measured. The results showed that the growth
rate of Tet-FAK-Y397F/v-Src cells was faster
Figure 5. The PI3K/AKT pathway is important for the FAK Y397F mutant to promote v-Src-stimulated Matrigel invasion. (a)
The expression of the FAK Y397F mutant was induced (I) or un-induced (U) in Tet-FAK-Y397F/Hygro cells and Tet-FAK-
Y397F/v-Src cells. Forty-eight hours later, the cells were lyzed and equal amounts of the cell lysates was analyzed by immuno-
blotting with antibodies speciﬁc to the molecules as indicated. The levels of phosphorylated AKT, ERK, JNK, and STAT3 were
measured and expressed as – fold relative to those in Tet-FAK-Y397F/Hygro cells without induction of the Y397F mutant. The
value (mean ± SE) was from three experiments. (b) Forty-eight hours after induction, the cells as described in the panel A were
subjected to a Matrigel invasion assay in the presence or absence of SP600125 (the JNK inhibitor), PD98059 (the MEK inhibitor),
wortmannin (the PI3K inhibitor), or the control solvent Me2SO (DMSO). The experiments were performed in duplicate. The value
(mean ± SE) was from six data points from three experiments. (c) Tet-FAK-Y397F/v-Src cells were allowed to express the Y397F
mutant in the medium with 10% serum. Twenty-four hours later, the medium was replaced by serum-free medium with or without
wortmannin. Twelve hours later, the conditioned medium was collected and analyzed for the expression of MMP-2 by immuno-
blotting. The cell lysates were analyzed by immunoblotting with anti-FAK. (b) Increasing amounts of the HA-tagged kinase-
deﬁcient (KD) mutant of AKT were transiently expressed in Tet-FAK-Y397F/v-Src cells in tetracycline-free medium. Forty-eight
hours later, the cells were subjected to a Matrigel invasion assay or lysed to verify the expression of HA-tagged KD mutant of
AKT by immunoblotting with anti-HA. The quantitative value (mean ± SE) of the Matrigel invasion assay was from three
experiments.
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than Tet-FAK-Y397F/Hygro cells regardless of
induction of the Y397F mutant (Figure 6a),
rendering it unlikely that the inhibitory eﬀect
of FAK Y397F mutant on v-Src-stimulated
tumor growth was due to its eﬀect on cell
proliferation. In fact, the failure of Tet-FAK-
Y397F/v-Src cells to grow in soft agar upon
FAK Y397F induction (Figure 4a) suggested
that the FAK Y397F mutant might render
v-Src-transformed cells susceptible to anoikis, a
type of cell death induced by the loss of cell-
matrix adhesion. To examine this possibility,
Tet-FAK-Y397F/v-Src cells with or without
induction of the FAK Y397F mutant were
subjected to an anoikis assay by suspending the
cells in methylcellulose, as described previously
[52]. Without the FAK Y397F induction, the
survival rate of Tet-FAK-Y397F/v-Src cells was
approximately 50% higher than that of Tet-
FAK-Y397F/Hygro cells (Figure 6b), supporting
a role for v-Src in suppressing anoikis, as
described [53]. Importantly, upon induction of
the Y397F mutant, the survival rate of Tet-
FAK-Y397F/v-Src cells was 40% decreased (Fig-
ure 6b), indicating that FAK Y397 mutant is
able to antagonize the anti-anoikis potential of
v-Src.
To examine the mechanism under this phe-
nomenon, the eﬀect of FAK Y397F mutant on the
activation of AKT, ERK, JNK, and NFjB was
examined. We found that although the FAK Y397
mutant selectively promoted the activation of
AKT and ERK in attached cells (Figure 5a), it
inhibited v-Src-stimulated activation of both
molecules in the cells suspended in methylcellulose
(Figure 6c). The phosphorylation of JNK was
hardly detected in suspended cells (Figure 6c). In
addition, we found that the phosphorylation of
IjB was not changed during anoikis, suggesting
that the NFjB pathway is not involved in the cell
regulation for anoikis. These results indicate that
FAK Y397F mutant could play either positive or
negative role in v-Src-stimulated activation of
certain signaling molecules, such as AKT and
ERK, depending on whether cells are attached or
not. The signiﬁcance of the AKT and ERK
activation in v-Src-stimulated resistance to anoikis
was demonstrated by using the speciﬁc inhibi-
tors of PI3K and MEK, which suppressed
v-Src-stimulated cell survival in methylcellulose
(data not shown).
The induction of the Y397F mutant leads to a
decreased level of p130 Cas in v-Src-transformed
cells during anoikis
To understand how the FAK Y397F mutant
exerts its dominant negative eﬀect on v-Src-
stimulated activation of AKT and ERK in the
cells kept in suspension, we compared the tyrosine
phosphorylation level of the FAK Y397F mutant
between attached cells and suspended cells. We
found that the phosphorylation of the Y397F
mutant was much lower in the suspended cells
than in attached cells (Figure 7a), suggesting that
cell adhesion is required for eﬃcient phosphoryla-
tion of FAK by v-Src. However, because v-Src
could still stimulate activation of AKT and ERK
in the cells even without FAK expression, the
result in Figure 7a did not explain why the Y397F
mutant possesses a dominant negative eﬀect on
v-Src-stimulated activation of AKT and ERK.
Next, we turned to examine whether the Y397F
mutant modulates the intracellular levels of certain
focal adhesion proteins during anoikis. Among the
molecules examined in this study, we found that
the induction of the Y397F mutant selectively led
to a decreased level of p130Cas, but not other focal
adhesion proteins, including talin, vinculin, and
paxillin, in suspended Tet-FAK-Y397F/v-Src cells
(Figure 7b), suggesting that FAK may be able to
modulate the level of p130Cas when the cells
encounter anoikis stress.
Discussion
In this study, we demonstrate that v-Src is capable
of inducing oncogenic transformation of MEF
FAK)/) cells, characterized by morphological
transformation and acquisition of invasiveness,
anchorage-independent growth, and tumorigenic-
ity. Our results support the notion that FAK is not
essential for v-Src to induce cell transformation, as
proposed by Roy et al. [54]. However, the current
study provides the ﬁrst evidence that the FAK
Y397F mutant has both positive and negative
eﬀects on the transforming potential of v-Src; it
promotes v-Src-stimulated invasion, but sup-
presses v-Src-stimulated anchorage-independent
cell growth in vitro and tumorigenicity in vivo.
To exclude the possibility that the observed
changes in the transformed phenotypes of
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Tet-FAK-Y397F/v-Src cells might be caused by the
Tet transactivator rather than the Y397F mutant,
we had established a control v-Src-transformed
FAK)/) cell line harboring the plasmid encoding
the Tet transactivator. We conﬁrmed that the
transformed characteristics of v-Src-transformed
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FAK)/) cells were not aﬀected by the Tet transac-
tivator no matter whether tetracycline was present
(data not shown).
Although we thought about comparing the
eﬀects of wt FAK and its Y397F mutant on
v-Src-stimulated cell transformation on the basis
of the same study model, we had diﬃculties in
doing this. The major challenge was that the
induced level of wt FAK was much lower than the
level of the Y397F mutant in v-Src-transformed
FAK)/) cells (data not shown). Although we had
examined several cell clones derived from separate
experiments, we failed to obtain cells that express
wt FAK at the level similar to that of the Y397F
mutant in v-Src-transformed FAK)/) cells upon
tetracycline withdrawal. Because v-Src-induced
cell transformation has previously been shown to
be accompanied by calpain-mediated cleavage of
FAK [55], we speculate that the wt FAK may be
more vulnerable to degradation than the Y397F
mutant in v-Src-transformed FAK)/) cells.
Previous studies have shown that FAK plays
an important role in v-Src-stimulated cell invasion
[56, 57]. In particular, Hsia et al. [57] showed that
stable re-expression of wt FAK was required for
v-Src to induce an invasive phenotype of FAK)/)
cells. Notably, they found that adenovirus-
mediated expression of the FAK Y397F mutant
in v-Src-expressed FAK)/) cells failed to promote
invasion. In contradiction with their results, we
found that induction of the FAK Y397F mutant in
v-Src-transformed FAK)/) cells markedly elevated
their invasiveness (Figure 3). The answer for this
discrepancy is currently unknown. It could be due
to clonal variation of the FAK)/) cells used in
both studies or diﬀerences between both studies in
the approach used for the expression of the Y397F
mutant, the expression level of the Y397F mutant
in the cells, the eﬃciency of the Y397F mutant
being phosphorylated by v-Src, and the eﬀect of
the Y397F mutant on cell morphology. We
showed that the Y397F mutant was highly phos-
phorylated in v-Src-transformed FAK)/) cells
(Figure 1) and localized in focal adhesions (Fig-
ure 2), indicating that the Tyr-397 of FAK is not
required for its targeting to focal adhesions and
phosphorylation by v-Src, as described previously
[58]. Importantly, the Y397F mutant was able
to reverse the long spindle morphology of the
v-Src-transformed FAK)/)cells into a more spread
cell shape, concomitant with a more organized
Figure 7. FAK Y397F mutant decreases the level of p130Cas
in v-Src-transformed cells during anoikis. (a) The expression
of the FAK Y397F mutant was induced (I) or un-induced (U)
in Tet-FAK-Y397F/Hygro cells and Tet-FAK-Y397F/v-Src
cells. Forty-eight hours after induction, the cells were sus-
pended in 0.5% methylcellulose. Ten hours later, the cells
were collected and lyzed. An equal amount of cell lysates
from the cells suspended in methylcellulose and those at-
tached on culture dishes was subjected to analysis for the
expression and phosphorylation of FAK and Src, as de-
scribed in Figure 1a. (b) An equal amount of cell lysates as
described in the panel A was analyzed by immunoblotting for
the expression of p130Cas, talin, vinculin, paxillin, and b-tubulin.
Figure 6. FAK Y397F mutant increases the susceptibility of
v-Src-transformed cells to anoikis. (a) 104 of Tet-FAK-
Y397F/Hygro cells or Tet-FAK-Y397F/v-Src cells were see-
ded on 100-mm culture dishes in the medium supplemented
with 10% or 1% serum in the presence or absence of tetracy-
cline. The number of cells was counted every day for three
days. The value is the average of three experiments. (b) The
expression of the FAK Y397F mutant was induced (I) or un-
induced (U) in Tet-FAK-Y397F/Hygro cells and Tet-FAK-
Y397F/v-Src cells. Forty-eight hours after induction, the cells
were suspended in 0.5% methylcellulose in the presence or ab-
sence of tetracycline. Ten hours later, the cells were harvested
by centrifugation and their survival rate was determined by
trypan blue exclusion. (c) The cells as described in the panel
B were harvested and lyzed. An equal amount of cell lysates
was analyzed by immunoblotting with antibodies speciﬁc to
molecules as indicated. The levels of phosphorylated AKT,
ERK, JNK, and IjB were measured and expressed as – fold
relative to those in Tet-FAK-Y397F/Hygro cells without
induction of the FAK Y397F mutant. The value
(mean ± SE) was from three experiments.
b
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actin cytoskeleton and an increased formation of
focal adhesions (Figure 2). Although the under-
lying mechanisms for those phenomena are not
clear yet, it is possible that the reversion of
v-Src-transformed cell morphology by the Y397F
mutant may underscore the observed changes
described in this report.
It has been shown that the ability of FAK to
promote v-Src-stimulated cell invasion is at least
partially through its stimulatory eﬀect on the
expression of MMPs [56, 57]. Similarly, we found
that elevated invasiveness of v-Src-transformed
FAK)/)cells by the Y397F mutant was correlated
with increased expression of MMP2 and, possibly,
MMP9 (Figure 3). In our attempt to identify the
signal transduction pathways important for the
Y397F mutant to promote v-Src-stimulated cell
invasion and MMP2 expression, we found that the
PI3K pathway was essential for both events
(Figure 5). The role of PI3K in cell invasion has
been extensively studied [59, 60]. It has been shown
to promote cell invasion through activation of
Rac, a small GTPase Rho family protein known to
play a key role in the formation of lamellipodia
and invasion [59, 60]. In addition, the PI3K/AKT
signaling pathway was reported to transcription-
ally activate the expression of MMP through the
activation of NFjB [61]. Thus, it was not too
surprising for us to ﬁnd the involvement of PI3K
in v-Src-stimulated cell invasion. The question is
how the Y397F contributes to the PI3K activation.
Given the fact that the Tyr397 of FAK is required
for its binding of the SH2 domain of the regula-
tory subunit of PI3K [31], the synergistic eﬀect of
the Y397F mutant on v-Src-stimulated activation
of the PI3K/AKT signaling pathway is likely
through an indirect mechanism rather than its
direct binding to PI3K.
We hypothesized that the Y397F mutant may
facilitate the interaction of certain cellular proteins
with v-Src and/or their phosphorylation by v-Src,
thereby leading to activation of PI3K. One of the
candidates ﬁt with our hypothesis is the docking
protein p130Cas. It has previously been shown
that p130Cas is highly phosphorylated in v-Src-
transformed cells and plays an essential role in
v-Src-induced cell transformation [46, 62]. In addi-
tion, expression of the SH3 domain of p130Cas
blocks v-Src-stimulated cell transformation, corre-
lated with decreased phosphorylation of endoge-
nous p130Cas in those cells [63]. We found in this
study that v-Src formed stable complexes with
p130Cas in v-Src-transformed FAK)/)cells and that
the tyrosine phosphorylation of p130Cas was further
increased upon induction of the Y397F mutant
(data not shown). The eﬀect of the Y397F mutant
on promoting p130Cas phosphorylation may be
through its binding to the SH3 domain of p130Cas,
bring v-Src and p130Cas in juxtaposition and/or
stabilizing their interaction, thereby leading to more
eﬃcient phosphorylation of p130Cas by v-Src. The
phosphorylation of p130Cas has been shown to link
to multiple signal transduction pathways, including
PI3K [64], ERK [65], and JNK [66].
Mounting evidence has indicated that the cell
adhesion is required for growth factors to transmit
appropriate signals into the cell [67]. Similarly, our
results here suggest that cell adhesion is also
required for v-Src to activate some, but not all, its
downstream signaling molecules. In this study we
found that JNK was only activated in attached
v-Src-transformed FAK)/)cells (Figure 5a), but
not in the suspended ones (Figure 6c). In contrast,
AKT and ERK were activated by v-Src no matter
whether the cells were attached or not (Figure 6c).
Moreover, the Y397F mutant markedly elevated
the potential of v-Src to activate AKT, ERK, and
JNK in attached v-Src-transformed FAK)/)cells
(Figure 5a). Unexpectedly, in suspended v-Src-
transformed FAK)/)cells, the Y397F mutant inhib-
ited rather than increased the v-Src-stimulated
activation of AKT and ERK (Figure 6c). This
inhibition in AKT and ERK by the Y397F mutant
may partially explain its inhibitory eﬀect on anoi-
kis resistance of v-Src-transformed FAK)/)cells
(Figure 6b). The mechanism by which the Y397F
mutant exerts such a dominant negative eﬀect on
v-Src-stimulated activation of AKT and ERK and
anoikis resistance is not clear. In this study, we
found that the amount of p130Cas was selectively
decreased in suspended v-Src-transformed FAK)/)
cells upon induction of the Y397F mutant (Fig-
ure 7b). The result from semi-quantitative reverse
transcription-polymerase chain reaction revealed
that the mRNA of p130Cas was not decreased
during anoikis (data not shown), suggesting the
decreased amount of p130Cas was not due to a
suppression at the transcriptional level. In fact, a
recent report [68] described that p130Cas speciﬁcally
underwent cleavage during anoikis and that over-
expression of the p130Cas cleavage product induced
apoptosis. Our results shown in Figure 7b suggest
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that FAK may facilitate the p130Cas cleavage
during anoikis.
Another interesting ﬁnding in this study is that
the Y397F mutant inhibits v-Src-stimulated
anchorage-independent growth of FAK)/)cells
(Figure 4). In fact, the role of FAK in anchorage-
independent cell growth has been previously
studied. Expression of a constitutively active
version of FAK (CD2-FAK) by anchoring it on
the plasma membrane conferred epithelial cells an
anchorage-independent growth potential [16]. Our
laboratory previously demonstrated that hepato-
cyte growth factor stimulated FAK independently
of cell adhesion [22] and that the synergistic eﬀect
of FAK overexpression and hepatocyte growth
factor stimulation allowed epithelial cells to grow
in soft agar [51]. These studies support the ideal if
the activation of FAK abnormally bypasses the
requirement of cell adhesion, it promotes anchorage-
independent cell growth. On the other hand, it
has been shown that expression of wt FAK in
v-Src-transformed FAK)/)cells suppressed their
potential to grow in soft agar [54, 69]. Similarly,
expression of a FAK mutant with ﬁve substitutions
at tyrosines Y407, Y576, Y577, Y861, and Y925
blocked v-Src-stimulated anchorage-independent
cell growth [70]. Together with our current results
derived from the Y397F mutant, it seems that FAK
antagonizes the anchorage-independent cell growth
independently of its autophosphorylation site or
known Src-phosphorylation sites. As discussed above,
FAK may inhibit anchorage-independent growth
by facilitating the cleavage of p130Cas, which is
already known to be required for v-Src-induced
cell transformation [46].
In summary, our results here convey a possibility
that FAK may have a dual function in oncogenic
transformation. It could promote cell invasion
through multiple mechanisms, for instance, by
promoting cell spreading, p130Cas phosphorylation,
and MMP expression. In contrast, it could inhibit
tumor cell growth by increasing cell susceptibility to
anoikis. The dual function of FAK in oncogenic
transformation may provide an explanation for
certain cancerous cells showing a tendency to invade
surrounding tissues rather than form a large tumor
mass in situ. The cells inside a large tumor mass have
less chance to contact with extracellular matrix
proteins and more likely to undergo anoikis. Experi-
ments are in progress to examine the mechanisms
by which FAK exerts its pro-anoikis function.
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